| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Tumor Biology |
Departments of Pathology [H. S. S.] and Behavioral Neuroscience [G. P. M.], Oregon Health and Science University, Portland, Oregon 97239; Department of Pathology and Laboratory Medicine, Boston University School of Medicine, Boston, Massachusetts 02118 [J. K. B.]; and Division of Neuroscience, Oregon National Primate Research Center, Beaverton, Oregon 97006 [H. S. S., P. S., Y. J., J. A. K., E. R. S.]
It is well established that small cell lung carcinomas (SCLCs) express receptors for acetylcholine (ACh) and that stimulation of these receptors by nicotine or other cholinergic agonists stimulates cell growth via activation of nicotinic cholinergic receptors (nAChRs) and/or muscarinic cholinergic receptors (mAChRs). The aim of this study was to determine whether SCLC cells synthesize and secrete ACh and respond to endogenous ACh to create a functioning cholinergic autocrine loop. Reverse transcription-PCR was used to screen a panel of SCLC cell lines for components of cholinergic signaling. Choline acetyltransferase (ChAT) and the vesicular ACh transporter (VAChT), as well as
3,
5,
7, ß2, and ß4, nAChR subunits and M3 and M5 mAChRs, were found to be present in most of the SCLC cell lines tested. Real-time PCR showed that mRNA levels for ChAT, VAChT, and
7 and ß2 nAChR subunits varied significantly among different SCLC cell lines tested. The H82 cell line was found to express the highest levels of ChAT, and that cell line was chosen for additional studies of ACh release and cell proliferation. ACh was easily detectable in H82 cell culture media, and levels of ACh were increased by the acetylcholinesterase inhibitor neostigmine. Vesamicol, an inhibitor of VAChT, and hemicholinium-3, an inhibitor of choline transport, both reduced H82 cell ACh basal release in a dose-dependent manner. In parallel with the reductions of ACh release, vesamicol and hemicholinium-3 also decreased H82 cell proliferation. H82 cell proliferation was also inhibited by the muscarinic and nicotinic antagonists atropine and mecamylamine, respectively, in dose- and time-dependent manners. Finally, archival cases of SCLC were screened by immunohistochemistry for expression of ChAT. Thirteen of 26 tumors screened were positive for ChAT. These findings demonstrate that SCLC can synthesize, secrete, and degrade ACh and that released ACh stimulates SCLC cell growth. Identification of this new autocrine loop provides a potential new target for therapeutic intervention.
This article has been cited by other articles:
![]() |
P. Song, H. S. Sekhon, X. W. Fu, M. Maier, Y. Jia, J. Duan, B. J. Proskosil, C. Gravett, J. Lindstrom, G. P. Mark, et al. Activated Cholinergic Signaling Provides a Target in Squamous Cell Lung Carcinoma Cancer Res., June 15, 2008; 68(12): 4693 - 4700. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zheng, J. D. Ritzenthaler, J. Roman, and S. Han Nicotine Stimulates Human Lung Cancer Cell Growth by Inducing Fibronectin Expression Am. J. Respir. Cell Mol. Biol., December 1, 2007; 37(6): 681 - 690. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. C.-l. Lam, L. Girard, R. Ramirez, W.-s. Chau, W.-s. Suen, S. Sheridan, V. P.C. Tin, L.-p. Chung, M. P. Wong, J. W. Shay, et al. Expression of Nicotinic Acetylcholine Receptor Subunit Genes in Non-Small-Cell Lung Cancer Reveals Differences between Smokers and Nonsmokers Cancer Res., May 15, 2007; 67(10): 4638 - 4647. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Song, H. S. Sekhon, A. Lu, J. Arredondo, D. Sauer, C. Gravett, G. P. Mark, S. A. Grando, and E. R. Spindel M3 Muscarinic Receptor Antagonists Inhibit Small Cell Lung Carcinoma Growth and Mitogen-Activated Protein Kinase Phosphorylation Induced by Acetylcholine Secretion Cancer Res., April 15, 2007; 67(8): 3936 - 3944. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Martinez-Moreno, S. Nieto-Ceron, J. Torres-Lanzas, F. Ruiz-Espejo, I. Tovar-Zapata, P. Martinez-Hernandez, J. N. Rodriguez-Lopez, C. J. Vidal, and J. Cabezas-Herrera Cholinesterase activity of human lung tumours varies according to their histological classification Carcinogenesis, March 1, 2006; 27(3): 429 - 436. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. S. Lips, C. Volk, B. M. Schmitt, U. Pfeil, P. Arndt, D. Miska, L. Ermert, W. Kummer, and H. Koepsell Polyspecific Cation Transporters Mediate Luminal Release of Acetylcholine from Bronchial Epithelium Am. J. Respir. Cell Mol. Biol., July 1, 2005; 33(1): 79 - 88. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Tsurutani, S.S. Castillo, J. Brognard, C. A. Granville, C. Zhang, J. J. Gills, J. Sayyah, and P. A. Dennis Tobacco components stimulate Akt-dependent proliferation and NF{kappa}B-dependent survival in lung cancer cells Carcinogenesis, July 1, 2005; 26(7): 1182 - 1195. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. G. Pomper, E. Phillips, H. Fan, D. J. McCarthy, R. A. Keith, J. C. Gordon, U. Scheffel, R. F. Dannals, and J. L. Musachio Synthesis and Biodistribution of Radiolabeled {alpha}7 Nicotinic Acetylcholine Receptor Ligands J. Nucl. Med., February 1, 2005; 46(2): 326 - 334. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. N. Ye, E. S. L. Liu, V. Y. Shin, W. K. K. Wu, and C. H. Cho The Modulating Role of Nuclear Factor-{kappa}B in the Action of {alpha}7-Nicotinic Acetylcholine Receptor and Cross-Talk between 5-Lipoxygenase and Cyclooxygenase-2 in Colon Cancer Growth Induced by 4-(N-Methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone J. Pharmacol. Exp. Ther., October 1, 2004; 311(1): 123 - 130. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. J. Proskocil, H. S. Sekhon, Y. Jia, V. Savchenko, R. D. Blakely, J. Lindstrom, and E. R. Spindel Acetylcholine Is an Autocrine or Paracrine Hormone Synthesized and Secreted by Airway Bronchial Epithelial Cells Endocrinology, May 1, 2004; 145(5): 2498 - 2506. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Ferguson and R. D. Blakely The Choline Transporter Resurfaces: New Roles for Synaptic Vesicles? Mol. Interv., February 1, 2004; 4(1): 22 - 37. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Trombino, A. Cesario, S. Margaritora, P. Granone, G. Motta, C. Falugi, and P. Russo {alpha}7-Nicotinic Acetylcholine Receptors Affect Growth Regulation of Human Mesothelioma Cells: Role of Mitogen-Activated Protein Kinase Pathway Cancer Res., January 1, 2004; 64(1): 135 - 145. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. R. Spindel Neuronal nicotinic acetylcholine receptors: not just in brain Am J Physiol Lung Cell Mol Physiol, December 1, 2003; 285(6): L1201 - L1202. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |